Autonomy Launches Tesla Model 3 EV Subscription Program

Got To Article
NextCar Holding Company (NXCR), the fintech and insurtech vehicle subscription platform founded by serial auto retail, auto finance and insurtech entrepreneurs Scott Painter and Georg Bauer, has launched an electric vehicle and zero emissions vehicle subscription program starting with the Tesla Model 3,
0 comments

Opiant Pharmaceuticals Announces First Patient Dosed in Phase 2 Trial of OPNT002, Nasal Naltrexone, for Alcohol Use Disorder

Got To Article
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced that the first patient has been dosed in a Phase 2 clinical trial of OPNT002, nasal naltrexone, for the treatment of Alcohol Use Disorder (“AUD”).
0 comments